MEA Karyotyping Market Market - Industry Trends and Forecast to 2033
Middle East and Africa karyotyping market is expected to reach USD 10,483.95 thousand by 2030 from USD 7,889.11 thousand in 2022, growing at a CAGR of 3.7% during the forecast period of 2023 to 2030.
Market SegmentationMiddle East and Africa Karyotyping Market, By Product (Instruments, Software & Services, and Consumables & Accessories), Type (Spectral Karyotyping, and Virtual Karyotyping), Application (Diagnosis, Personalized Medicines, Research, and Others), End User (Clinical & Research Laboratories, Hospitals, Pathology Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Oman, Qatar, Bahrain, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Middle East and Africa Karyotyping Market Dynamics
Driver
• Increasing cases of chromosomal abnormalities and adoption of sequencing testing
Restraint
• High cost of karyotyping testing
Opportunity
• Increasing technological advancements and innovation of new medical devices and instruments
Market Players
Some of the major market players operating in the Middle East and Africa karyotyping market are:• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Sartorius AG
• Abbott
• Leica Biosystems Nussloch GmbH
• PerkinElmer Inc.
• BioDot
• Bio-Rad Laboratories, Inc
• Creative Bioarray
• Applied Spectral Imaging
• West Medica Produktions- und Handels- GmbH
• Capricorn Scientific
• Laboratory Imaging s.r.o.
• SciGene Corporation
• MICROPTIC